Cite
Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions.
MLA
Khanh, Vuong Cat, et al. “Wharton’s Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions.” Stem Cells & Development, vol. 30, no. 15, Aug. 2021, pp. 758–72. EBSCOhost, https://doi.org/10.1089/scd.2021.0065.
APA
Khanh, V. C., Fukushige, M., Chang, Y. H., Hoang, N. N., Yamashita, T., Obata-Yasuoka, M., Hamada, H., Osaka, M., Hiramatsu, Y., & Ohneda, O. (2021). Wharton’s Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions. Stem Cells & Development, 30(15), 758–772. https://doi.org/10.1089/scd.2021.0065
Chicago
Khanh, Vuong Cat, Mizuho Fukushige, Yun Hsuan Chang, Ngo Nhat Hoang, Toshiharu Yamashita, Mana Obata-Yasuoka, Hiromi Hamada, Motoo Osaka, Yuji Hiramatsu, and Osamu Ohneda. 2021. “Wharton’s Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions.” Stem Cells & Development 30 (15): 758–72. doi:10.1089/scd.2021.0065.